Clarity Pharmaceuticals Ltd. (AU:CU6) has released an update.
Clarity Pharmaceuticals Ltd has announced the final director’s interest notice for Robert Bain Thomas, who ceased to be a director on August 23, 2024. Thomas held 575,000 fully paid ordinary shares as a registered holder and had interests in 600,000 additional shares through various trusts and entities. This update follows the requirements of the ASX listing rules and the Corporations Act.
For further insights into AU:CU6 stock, check out TipRanks’ Stock Analysis page.
